GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
Clinical trial NCT01315496 · TERMINATED
Trial details
- NCT number
- NCT01315496
- Sponsor
- Green Cross Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2013-12-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.